Related references
Note: Only part of the references are listed.Purple corn color inhibition of prostate carcinogenesis by targeting cell growth pathways
Ne Long et al.
CANCER SCIENCE (2013)
Apocynin, an NADPH oxidase inhibitor, suppresses progression of prostate cancer via Rac1 dephosphorylation
Shugo Suzuki et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2013)
Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation
Yong Tang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer
Satoru Takahashi et al.
PROSTATE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c
Fred Saad et al.
CLINICAL CANCER RESEARCH (2011)
The clusterin paradigm in prostate and breast carcinogenesis
Federica Rizzi et al.
ENDOCRINE-RELATED CANCER (2010)
Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
Kim N. Chi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Oxidative stress in prostate cancer
Lakshmipathi Khandrika et al.
CANCER LETTERS (2009)
Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway
Teh-Ying Chou et al.
CELLULAR SIGNALLING (2009)
Evaluation of the Antioxidant Properties of N-acetylcysteine in Human Platelets: Prerequisite for Bioconversion to Glutathione for Antioxidant and Antiplatelet Activity
Kyle R. Gibson et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium
Shugo Suzuki et al.
TOXICOLOGY (2009)
Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype
Binod Kumar et al.
CANCER RESEARCH (2008)
Apocynin: Molecular Aptitudes
J. Stefanska et al.
MEDIATORS OF INFLAMMATION (2008)
Prostate cancer chemoprevention: Current status and future prospects
Sanjay Gupta
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
The signaling mechanism of ROS in tumor progression
Wen-Sheng Wu
CANCER AND METASTASIS REVIEWS (2006)
Extracellular adenosine triphosphate protects oxidative stress-induced increase of p21WAF1/Cip1 and P27Kip1 expression in primary cultured renal proximal tubule cells:: Role of PI3K and Akt signaling
Yun Jung Lee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control
B. Shannan et al.
JOURNAL OF MOLECULAR HISTOLOGY (2006)
Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer
B Shannan et al.
CELL DEATH AND DIFFERENTIATION (2006)
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation
D Ahuja et al.
ONCOGENE (2005)
Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
ZW Wang et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression
A Caporali et al.
CARCINOGENESIS (2004)
Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: Lack of influence of carcinogen or testosterone treatment
YM Cho et al.
CANCER SCIENCE (2003)
Share Paper
